XML 26 R15.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Intangible Assets | 9 Months Ended
--- | ---
Sep. 30, 2018
Intangible Assets, Net (Excluding Goodwill) [Abstract] |
Intangible Assets | INTANGIBLE ASSETS The following table summarizes our intangible assets, net (in millions):
|  | September 30, 2018 |  | December 31, 2017
|  | Gross Carrying Amount |  | Accumulated Amortization |  | Foreign Currency Translation Adjustment |  | Net Carrying Amount |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Carrying Amount
Finite-lived intangible assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Intangible asset - sofosbuvir |  | $ | 10,720 |  |  | $ | (3,379 | ) |  | $ | — |  |  | $ | 7,341 |  |  | $ | 10,720 |  |  | $ | (2,855 | ) |  | $ | 7,865 |
Intangible asset - axicabtagene ciloleucel (DLBCL) |  | 6,200 |  |  | (330 | ) |  | — |  |  | 5,870 |  |  | 6,200 |  |  | (72 | ) |  | 6,128 |
Intangible asset - Ranexa |  | 688 |  |  | (650 | ) |  | — |  |  | 38 |  |  | 688 |  |  | (566 | ) |  | 122 |
Other |  | 546 |  |  | (347 | ) |  | (1 | ) |  | 198 |  |  | 546 |  |  | (311 | ) |  | 235 |
Total finite-lived intangible assets |  | 18,154 |  |  | (4,706 | ) |  | (1 | ) |  | 13,447 |  |  | 18,154 |  |  | (3,804 | ) |  | 14,350 |
Indefinite-lived intangible assets - IPR&D |  | 2,867 |  |  | — |  |  | — |  |  | 2,867 |  |  | 2,750 |  |  | — |  |  | 2,750 |
Total intangible assets |  | $ | 21,021 |  |  | $ | (4,706 | ) |  | $ | (1 | ) |  | $ | 16,314 |  |  | $ | 20,904 |  |  | $ | (3,804 | ) |  | $ | 17,100 |
Amortization expense related to finite-lived intangible assets is included in Cost of goods sold on our Condensed Consolidated Statements of Income and totaled $301 million and $902 million for the three and nine months ended September 30, 2018, respectively, and $209 million and $629 million for the three and nine months ended September 30, 2017, respectively. As of September 30, 2018, the estimated future amortization expense associated with our finite-lived intangible assets is as follows (in millions):
Fiscal Year |  | Amount
2018 (remaining three months) |  | $ | 301 |
2019 |  | 1,088 |
2020 |  | 1,064 |
2021 |  | 1,064 |
2022 |  | 1,064 |
Thereafter |  | 8,866 |
Total |  | $ | 13,447 |

X
- Definition The entire disclosure for all or part of the information related to intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration